The scopolamine model as a pharmacodynamic marker in early drug development
暂无分享,去创建一个
K. Wesnes | W. Abi-Saab | M. Saltarelli | E. Mohler | C. Locke | R. Lenz | L. Rueter | J. Baker
暂无分享,去创建一个
K. Wesnes | W. Abi-Saab | M. Saltarelli | E. Mohler | C. Locke | R. Lenz | L. Rueter | J. Baker